Mr. Antonio Baldassarre reports

UNIDOC - ANNOUNCES FILING OF AMENDED AND RESTATED INTERIM MANAGEMENT DISCUSSION AND ANALYSIS

Unidoc Health Corp. has been subject to a continuous disclosure review by the British Columbia Securities Commission. In connection therewith, the company has filed amended and restated management's discussion and analysis (MD&A) for the six-month period ended Sept. 30, 2024, to clarify its disclosure.

Amended and restated management's discussion and analysis

The company has amended and restated its interim management's discussion and analysis for the six-month period ended Sept. 30, 2024, to include the following clarifying disclosure:

1. Nature of the company's business;
2. Recent developments;
3. The company's contractual agreements;
4. Explanation relating to advertising cost incurred by the company.

The amended and restated MD&A has been filed under the company's issuer profile on SEDAR+.

About Unidoc Health Corp.

Unidoc is developing an e-health solution, which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. E-health opens the doors to a large segment of the population challenged by access, experience or understanding of on-line computer technology. It is the company's belief that physical accessibility is the key to its business proposition. Unidoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited time frame.

We seek Safe Harbor.